Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04298086

A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer

Pharmacodynamic Response to Exercise Treatment and Plant-Based Diet in Overweight/Obese Postmenopausal Women With Primary Hormone Receptor Positive Breast Cancer: A Phase 2 Randomized Control Trial

Status
Active Not Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
43 (actual)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find out what effects, if any, exercise and a plant-based diet have on aromatase levels in postmenopausal women who are overweight and being treated with an aromatase inhibitor for their HR+ breast cancer. The study will also look at other ways diet and exercise may affect your body (for example, changing the way your breast tissue expresses or makes genes) and your quality of life.

Conditions

Interventions

TypeNameDescription
OTHERExercise TreatmentExercise treatment will consist of individualized walking delivered up to 7 times weekly to achieve the patient-specific goal energy expenditure. Training sessions will be performed on a treadmill at under remote surveillance using a telemedicine approach (i.e.,TeleEx) established in the Exercise-Oncology (ExOnc) Service.
OTHERPlant-Based DietPre-prepared meals, including 6 dinners and 6 lunches per week, will be shipped to the partipant's home during the intervention.
OTHERPhysical activityTreadmills and low-calorie recipes will be provided to patients in the counseling arm.
OTHERNutrition counselingNutrition program including regular counseling by exercise physiologists and registered dieticians (RDs).
OTHERReplication Exercise TestExercise capacity will be reassessed by a replication exercise test at week 6 in the intervention group only.

Timeline

Start date
2020-03-04
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2020-03-06
Last updated
2025-07-11

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04298086. Inclusion in this directory is not an endorsement.